June Sherie Almenoff

CIK 1492647 · COO and Chief Medical Officer · last filed 2026-01-13

June Sherie Almenoff is a COO and Chief Medical Officer who has filed 46 SEC Form 4 insider transactions across 7 companies since 2010. The most recent filing, for TENX, was dated Jan 13, 2026. Across all open-market trades the lifetime net is −$13.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $117.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$117.1K

Companies

7

Total Filings

46

Lifetime Open-Market Net

-$13.02M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TENX Director 3,986 $11.48 $45.8K $29.9K 7 2026-01-13
AVTX Director 4,167 $14.76 $61.5K $12.7K 14 2025-06-18
ATNM Director $1.01 $0 2 2025-04-02
BCLI Director 13,175 $0.75 $9.9K $25.0K 6 2021-12-17
9 METERS BIOPHARMA, INC. (INNT) Delisted COO and Chief Medical Officer 1,400 $6.9K 1 2018-08-28
NeuBase Therapeutics, Inc. (OHRP) Delisted Director 16,900 $58.3K 5 2017-10-18
Furiex Pharmaceuticals, Inc. (FURX) Delisted President 139,713 -$13.15M 10 2014-02-06

Recent Filings

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-13 TENX Grant (A) $0 EDGAR
2025-11-20 TENX Buy (P) +1,993 $14.9K EDGAR
2025-11-19 TENX Buy (P) +1,993 $14.9K EDGAR
2025-07-03 TENX Grant (A) $0 EDGAR
2025-06-18 AVTX Grant (A) $0 EDGAR
2025-04-02 ATNM Disp (D) $0 EDGAR
2025-04-01 AVTX Exer (M) +3,167 $0 EDGAR
2024-12-12 TENX Grant (A) $0 EDGAR
2024-11-14 AVTX Buy (P) +1,000 $12.7K EDGAR
2024-11-05 ATNM Grant (A) $0 EDGAR
Showing 110 of 46
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.